1 |
Hess, J., Porte, D., Munz, C., and Angel, P. (2001). AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem. 276, 20029-20038.
DOI
|
2 |
Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W., and Hartmann, C. (2005). Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727-738.
DOI
|
3 |
Hirata, M., Kugimiya, F., Fukai, A., Saito, T., Yano, F., Ikeda, T., Mabuchi, A., Sapkota, B.R., Akune, T., Nishida, N., et al. (2012). C/EBPbeta and RUNX2 cooperate to degrade cartilage with MMP-13 as the target and HIF-2alpha as the inducer in chondrocytes. Hum. Mol. Genet. 21, 1111-1123.
DOI
|
4 |
Hu, H., Hilton, M.J., Tu, X., Yu, K., Ornitz, D.M., and Long, F. (2005). Sequential roles of hedgehog and Wnt signaling in osteoblast development. Development 132, 49-60.
DOI
|
5 |
Huang, L.F., Fukai, N., Selby, P.B., Olsen, B.R., and Mundlos, S. (1997). Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice. Dev. Dyn. 210, 33-40.
DOI
|
6 |
Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., Sato, M., Yamagiwa, H., Kimura, T., Yasui, N., et al. (1999). Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214, 279-290.
DOI
|
7 |
Iwamoto, M., Kitagaki, J., Tamamura, Y., Gentili, C., Koyama, E., Enomoto, H., Komori, T., Pacifici, M., and Enomoto-Iwamoto, M. (2003). Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP). Osteoarthr. Cartil. 11, 6-15.
DOI
|
8 |
Jiang, Q., Qin, X., Kawane, T., Komori, H., Matsuo, Y., Taniuchi, I., Ito, K., Izumi, S.I., and Komori, T. (2016). Cbfb2 isoform dominates more potent Cbfb1 and is required for skeletal development. J. Bone Miner. Res. 31, 1391-1404.
DOI
|
9 |
Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., et al. (1997). Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771.
DOI
|
10 |
Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G., and Downing, J.R. (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330.
DOI
|
11 |
Qin, X., Jiang, Q., Matsuo, Y., Kawane, T., Komori, H., Moriishi, T., Taniuchi, I., Ito, K., Kawai, Y., Rokutanda, S., et al. (2015). Cbfb regulates bone development by stabilizing Runx family proteins. J. Bone Miner. Res. 30, 706-714.
DOI
|
12 |
Owens, T.W., Rogers, R.L., Best, S.A., Ledger, A., Mooney, A.M., Ferguson, A., Shore, P., Swarbrick, A., Ormandy, C.J., Simpson, P.T., et al. (2014). Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Res. 74, 5277-5286.
DOI
|
13 |
Park, O.J., Kim, H.J., Woo, K.M., Baek, J.H., and Ryoo, H.M. (2010). FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J. Biol. Chem. 285, 3568-3574.
DOI
|
14 |
Pratap, J., Galindo, M., Zaidi, S.K., Vradii, D., Bhat, B.M., Robinson, J.A., Choi, J.Y., Komori, T., Stein, J.L., and Lian, J.B. (2003). Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 63, 5357-5362.
|
15 |
Qin, X., Jiang, Q., Miyazaki, T., and Komori, T. (2019). Runx2 regulates cranial suture closure by inducing hedgehog, Fgf, Wnt and Pthlh signaling pathway gene expressions in suture mesenchymal cells. Hum. Mol. Genet. 28, 896-911.
DOI
|
16 |
Jimenez, M.J., Balbin, M., Lopez, J.M., Alvarez, J., Komori, T., and Lopez-Otin, C. (1999). Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol. Cell. Biol. 19, 4431-4442.
DOI
|
17 |
Xu, X., Weinstein, M., Li, C., Naski, M., Cohen, R.I., Ornitz, D.M., Leder, P., and Deng, C. (1998). Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125, 753-765.
DOI
|
18 |
Yoshida, C.A., Furuichi, T., Fujita, T., Fukuyama, R., Kanatani, N., Kobayashi, S., Satake, M., Takada, K., and Komori, T. (2002). Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat. Genet. 32, 633-638.
DOI
|
19 |
Yoshida, C.A., Komori, H., Maruyama, Z., Miyazaki, T., Kawasaki, K., Furuichi, T., Fukuyama, R., Mori, M., Yamana, K., Nakamura, K., et al. (2012). SP7 inhibits osteoblast differentiation at a late stage in mice. PLoS One 7, e32364.
DOI
|
20 |
Yoshida, C.A., Yamamoto, H., Fujita, T., Furuichi, T., Ito, K., Inoue, K., Yamana, K., Zanma, A., Takada, K., Ito, Y., et al. (2004). Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 18, 952-963.
DOI
|
21 |
Kim, I.S., Otto, F., Zabel, B., and Mundlos, S. (1999). Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev. 80, 159-170.
DOI
|
22 |
Kamekura, S., Kawasaki, Y., Hoshi, K., Shimoaka, T., Chikuda, H., Maruyama, Z., Komori, T., Sato, S., Takeda, S., Karsenty, G., et al. (2006). Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54, 2462-2470.
DOI
|
23 |
Kawane, T., Komori, H., Liu, W., Moriishi, T., Miyazaki, T., Mori, M., Matsuo, Y., Takada, Y., Izumi, S., Jiang, Q., et al. (2014). Dlx5 and mef2 regulate a novel Runx2 enhancer for osteoblast-specific expression. J. Bone Miner. Res. 29, 1960-1969.
DOI
|
24 |
Kawane, T., Qin, X., Jiang, Q., Miyazaki, T., Komori, H., Yoshida, C.A., Matsuura-Kawata, V., Sakane, C., Matsuo, Y., Nagai, K., et al. (2018). Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3. Sci. Rep. 8, 13551.
DOI
|
25 |
Komori, T. (2002). Runx2, a multifunctional transcription factor in skeletal development. J. Cell. Biochem. 87, 1-8.
DOI
|
26 |
Komori, T. (2018). Runx2, an inducer of osteoblast and chondrocyte differentiation. Histochem. Cell Biol. 149, 313-323.
DOI
|
27 |
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
DOI
|
28 |
Sasaki, K., Yagi, H., Bronson, R.T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., and Komori, T. (1996). Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc. Natl. Acad. Sci. U. S. A. 93, 12359-12363.
DOI
|
29 |
Rodda, S.J. and McMahon, A.P. (2006). Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 133, 3231-3244.
DOI
|
30 |
Sahar, D.E., Longaker, M.T., and Quarto, N. (2005). Sox9 neural crest determinant gene controls patterning and closure of the posterior frontal cranial suture. Dev. Biol. 280, 344-361.
DOI
|
31 |
Selvamurugan, N., Pulumati, M.R., Tyson, D.R., and Partridge, N.C. (2000). Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J. Biol. Chem. 275, 5037-5042.
DOI
|
32 |
Simpson, F., Kerr, M.C., and Wicking, C. (2009). Trafficking, development and hedgehog. Mech. Dev. 126, 279-288.
DOI
|
33 |
St-Jacques, B., Hammerschmidt, M., and McMahon, A.P. (1999). Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072-2086.
DOI
|
34 |
Takahashi, A., de Andres, M.C., Hashimoto, K., Itoi, E., Otero, M., Goldring, M.B., and Oreffo, R.O.C. (2017). DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes. Sci. Rep. 7, 7771.
DOI
|
35 |
Takarada, T., Hinoi, E., Nakazato, R., Ochi, H., Xu, C., Tsuchikane, A., Takeda, S., Karsenty, G., Abe, T., Kiyonari, H., et al. (2013). An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice. J. Bone Miner. Res. 28, 2064-2069.
DOI
|
36 |
Bradley, J.P., Levine, J.P., Roth, D.A., McCarthy, J.G., and Longaker, M.T. (1996). Studies in cranial suture biology: IV. temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast. Reconstr. Surg. 98, 1039-1045.
DOI
|
37 |
Adhami, M.D., Rashid, H., Chen, H., and Javed, A. (2014). Runx2 activity in committed osteoblasts is not essential for embryonic skeletogenesis. Connect. Tissue Res. 55 Suppl 1, 102-106.
|
38 |
Aubin, J.E. and Triffitt, J.T. (2002). Mesenchymal stem cells and osteoblast differentiation. In Principles of Bone Biology, J.P. Bilezikian, L.G. Raisz, and G.A. Rodan, eds. (Cambridge, MA: Academic Press), pp. 59-81.
|
39 |
Bauer, O., Sharir, A., Kimura, A., Hantisteanu, S., Takeda, S., and Groner, Y. (2015). Loss of osteoblast Runx3 produces severe congenital osteopenia. Mol. Cell. Biol. 35, 1097-1109.
DOI
|
40 |
Krishnan, V., Moore, T.L., Ma, Y.L., Helvering, L.M., Frolik, C.A., Valasek, K.M., Ducy, P., and Geiser, A.G. (2003). Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol. Endocrinol. 17, 423-435.
DOI
|
41 |
Kundu, M., Javed, A., Jeon, J.P., Horner, A., Shum, L., Eckhaus, M., Muenke, M., Lian, J.B., Yang, Y., Nuckolls, G.H., et al. (2002). Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat. Genet. 32, 639-644.
DOI
|
42 |
Lee, B., Thirunavukkarasu, K., Zhou, L., Pastore, L., Baldini, A., Hecht, J., Geoffroy, V., Ducy, P., and Karsenty, G. (1997). Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16, 307-310.
DOI
|
43 |
Lefebvre, V.R. and Smits, P. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res. C Embryo Today 75, 200-212.
DOI
|
44 |
Liao, L., Zhang, S., Gu, J., Takarada, T., Yoneda, Y., Huang, J., Zhao, L., Oh, C.D., Li, J., Wang, B., et al. (2017). Deletion of Runx2 in articular chondrocytes decelerates the progression of DMM-induced osteoarthritis in adult mice. Sci. Rep. 7, 2371.
DOI
|
45 |
Lim, K.E., Park, N.R., Che, X., Han, M.S., Jeong, J.H., Kim, S.Y., Park, C.Y., Akiyama, H., Kim, J.E., Ryoo, H.M., et al. (2015). Core binding factor beta of osteoblasts maintains cortical bone mass via stabilization of Runx2 in mice. J. Bone Miner. Res. 30, 715-722.
DOI
|
46 |
Thirunavukkarasu, K., Pei, Y., and Wei, T. (2007). Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter. Mol. Biol. Rep. 34, 225-231.
DOI
|
47 |
Long, F., Chung, U.I., Ohba, S., McMahon, J., Kronenberg, H.M., and McMahon, A.P. (2004). Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131, 1309-1318.
DOI
|
48 |
Lucero, C.M., Vega, O.A., Osorio, M.M., Tapia, J.C., Antonelli, M., Stein, G.S., Van Wijnen, A.J., and Galindo, M.A. (2013). The cancer‐related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. J. Cell. Physiol. 228, 714-723.
DOI
|
49 |
Taniuchi, I., Osato, M., Egawa, T., Sunshine, M.J., Bae, S.C., Komori, T., Ito, Y., and Littman, D.R. (2002). Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621-633.
DOI
|
50 |
Tetsunaga, T., Nishida, K., Furumatsu, T., Naruse, K., Hirohata, S., Yoshida, A., Saito, T., and Ozaki, T. (2011). Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells. Osteoarthr. Cartil. 19, 222-232.
DOI
|
51 |
Thomas, D.M., Johnson, S.A., Sims, N.A., Trivett, M.K., Slavin, J.L., Rubin, B.P., Waring, P., McArthur, G.A., Walkley, C.R., and Holloway, A.J. (2004). Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell Biol. 167, 925-934.
DOI
|
52 |
Ueta, C., Iwamoto, M., Kanatani, N., Yoshida, C., Liu, Y., Enomoto-Iwamoto, M., Ohmori, T., Enomoto, H., Nakata, K., Takada, K., et al. (2001). Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153, 87-100.
DOI
|
53 |
Vortkamp, A., Lee, K., Lanske, B., Segre, G.V., Kronenberg, H.M., and Tabin, C.J. (1996). Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science (New York, NY) 273, 613-622.
DOI
|
54 |
Enomoto, H., Enomoto-Iwamoto, M., Iwamoto, M., Nomura, S., Himeno, M., Kitamura, Y., Kishimoto, T., and Komori, T. (2000). Cbfa1 is a positive regulatory factor in chondrocyte maturation. J. Biol. Chem. 275, 8695-8702.
DOI
|
55 |
Cao, K., Wei, L., Zhang, Z., Guo, L., Zhang, C., Li, Y., Sun, C., Sun, X., Wang, S., Li, P., et al. (2014). Decreased histone deacetylase 4 is associated with human osteoarthritis cartilage degeneration by releasing histone deacetylase 4 inhibition of runt-related transcription factor-2 and increasing osteoarthritis-related genes: a novel mechanism of human osteoarthritis cartilage degeneration. Arthritis Res. Ther. 16, 491.
DOI
|
56 |
Catheline, S.E., Hoak, D., Chang, M., Ketz, J.P., Hilton, M.J., Zuscik, M.J., and Jonason, J.H. (2019). Chondrocyte-specific RUNX2 overexpression accelerates post-traumatic osteoarthritis progression in adult mice. J. Bone Miner. Res. 34, 1676-1689.
DOI
|
57 |
Takeda, S., Bonnamy, J.P., Owen, M.J., Ducy, P., and Karsenty, G. (2001). Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467-481.
DOI
|
58 |
Chen, W., Ma, J., Zhu, G., Jules, J., Wu, M., McConnell, M., Tian, F., Paulson, C., Zhou, X., Wang, L., et al. (2014). Cbfbeta deletion in mice recapitulates cleidocranial dysplasia and reveals multiple functions of Cbfbeta required for skeletal development. Proc. Natl. Acad. Sci. U. S. A. 111, 8482-8487.
DOI
|
59 |
Day, T.F., Guo, X., Garrett-Beal, L., and Yang, Y. (2005). Wnt/betacatenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750.
DOI
|
60 |
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754.
DOI
|
61 |
Harada, H., Tagashira, S., Fujiwara, M., Ogawa, S., Katsumata, T., Yamaguchi, A., Komori, T., and Nakatsuka, M. (1999). Cbfa1 isoforms exert functional differences in osteoblast differentiation. J. Biol. Chem. 274, 6972-6978.
DOI
|
62 |
Fei, T., Mengrui, W., Lianfu, D., Guochun, Z., Junqing, M., Bo, G., Lin, W., Yi‐ Ping, L., and Wei, C. (2014). Core binding factor beta (Cbf ) controls the balance of chondrocyte proliferation and differentiation by upregulating Indian hedgehog (Ihh) expression and inhibiting parathyroid hormonerelated protein receptor (PPR) expression in postnatal cartilage and bone formation. J. Bone Miner. Res. 29, 1564-1574.
DOI
|
63 |
Fujita, T., Azuma, Y., Fukuyama, R., Hattori, Y., Yoshida, C., Koida, M., Ogita, K., and Komori, T. (2004). Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J. Cell Biol. 166, 85-95.
DOI
|
64 |
Galindo, M., Pratap, J., Young, D.W., Hovhannisyan, H., Im, H.J., Choi, J.Y., Lian, J.B., Stein, J.L., Stein, G.S., and van Wijnen, A.J. (2005). The bonespecific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 280, 20274-20285.
DOI
|
65 |
Ge, C., Xiao, G., Jiang, D., Yang, Q., Hatch, N.E., Roca, H., and Franceschi, R.T. (2009). Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J. Biol. Chem. 284, 32533-32543.
DOI
|
66 |
Ghali, O., Chauveau, C., Hardouin, P., Broux, O., and Devedjian, J.C. (2010). TNF‐ 's effects on proliferation and apoptosis in human mesenchymal stem cells depend on RUNX2 expression. J. Bone Miner. Res. 25, 1616-1626.
DOI
|
67 |
Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779.
DOI
|
68 |
Maeno, T., Moriishi, T., Yoshida, C.A., Komori, H., Kanatani, N., Izumi, S., Takaoka, K., and Komori, T. (2011). Early onset of Runx2 expression caused craniosynostosis, ectopic bone formation, and limb defects. Bone 49, 673-682.
DOI
|
69 |
Maruyama, Z., Yoshida, C.A., Furuichi, T., Amizuka, N., Ito, M., Fukuyama, R., Miyazaki, T., Kitaura, H., Nakamura, K., Fujita, T., et al. (2007). Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev. Dyn. 236, 1876-1890.
DOI
|
70 |
Miller, J., Horner, A., Stacy, T., Lowrey, C., Lian, J.B., Stein, G., Nuckolls, G.H., and Speck, N.A. (2002). The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nat. Genet. 32, 645-649.
DOI
|
71 |
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
DOI
|
72 |
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., and Shigesada, K. (1993). Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194, 314-331.
DOI
|
73 |
Ohuchi, H., Nakagawa, T., Yamamoto, A., Araga, A., Ohata, T., Ishimaru, Y., Yoshioka, H., Kuwana, T., Nohno, T., Yamasaki, M., et al. (1997). The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development 124, 2235-2244.
DOI
|
74 |
Wu, M., Li, C., Zhu, G., Wang, Y., Jules, J., Lu, Y., McConnell, M., Wang, Y.J., Shao, J.Z., Li, Y.P., et al. (2014a). Deletion of core-binding factor beta (Cbfbeta) in mesenchymal progenitor cells provides new insights into Cbfbeta/Runxs complex function in cartilage and bone development. Bone 65, 49-59.
DOI
|
75 |
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H., and Speck, N.A. (1996a). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 93, 3444-3449.
DOI
|
76 |
Wang, Q., Stacy, T., Miller, J.D., Lewis, A.F., Gu, T.L., Huang, X., Bushweller, J.H., Bories, J.C., Alt, F.W., Ryan, G., et al. (1996b). The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87, 697-708.
DOI
|
77 |
Wang, X., Manner, P.A., Horner, A., Shum, L., Tuan, R.S., and Nuckolls, G.H. (2004). Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthr. Cartil. 12, 963-973.
DOI
|
78 |
Xiao, Z.S., Hjelmeland, A.B., and Quarles, L.D. (2004). Selective deficiency of the "bone-related" Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J. Biol. Chem. 279, 20307-20313.
DOI
|
79 |
Wu, M., Li, Y.P., Zhu, G., Lu, Y., Wang, Y., Jules, J., McConnell, M., Serra, R., Shao, J.Z., and Chen, W. (2014b). Chondrocyte-specific knockout of Cbfbeta reveals the indispensable function of Cbfbeta in chondrocyte maturation, growth plate development and trabecular bone formation in mice. Int. J. Biol. Sci. 10, 861-872.
DOI
|
80 |
Xiao, G., Jiang, D., Gopalakrishnan, R., and Franceschi, R.T. (2002). Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 277, 36181-36187.
DOI
|